City of Hope researchers found that a microRNA called miR-105 helps cancer metastasize by breaking down the building blocks of blood vessels' barriers, allowing the cancer cells to enter the bloodstream.
Researchers reveal novel cellular and molecular elements of muscle repair. The study explains how drugs can induce regeneration, while preventing fibrosis and fat deposition, in dystrophic muscle at early stages of Duchenne muscular dystrophy.
Stuart Lindsay and his colleagues at Arizona State University have taken a major step in demonstrating the accurate identification of amino acids by briefly pinning each in a narrow junction between a pair of flanking electrodes and measuring a characteristic chain of current spikes passing through successive amino acid molecules.
A team led by scientists at The Scripps Research Institute (TSRI) has identified a long-sought protein that facilitates one of the most basic functions of cells: regulating their volume to keep from swelling excessively.
Researchers have developed a new understanding of the T-cell recognition process by describing how T-cell receptors use mechanical contact – the forces involved in their binding to antigens – to make decisions about whether or not the cells they encounter are threats.
Building antibiotic compounds at the molecular level requires precision and specialized tools. NC State research may turn an enzyme that acts as a specialized “wrench” in antibiotic assembly into a set of wrenches that will allow for greater customization.
University of Montreal researchers have discovered how a component of the Epstein Barr (EBV) virus takes over our cells gene regulating machinery, allowing the virus to replicate itself.
As one of the most widely consumed and commercially important beverages on the planet, one would expect the experts to know everything there is to know about lager beer. Now, however, scientists are beginning to color in the margins of yeast ecology and genetics, identifying new strains in new environments and using the tools of molecular biology to ferret out traits that could aid industrial fermentation technologies.
The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation
Researchers at UAB report a genetically engineered herpes simplex viral therapy is safe when used in conjunction with radiation in the treatment of malignant gliomas, one of the most deadly forms of brain cancer.
The virus, G207, is a modified herpes simplex virus that in two previous UAB studies has been shown to be safe when used as a sole therapy. The new findings indicate the virus is also safe when used in combination with low doses of radiation therapy.
The University of Pennsylvania’s Institute for Regenerative Medicine will host a symposium on Friday, April 11, 2014 to detail the progress researchers are making toward reprogramming human cells to treat a variety of diseases.
Chlorine bleach has been used as a disinfectant for hundreds of years, but our bodies have been using its active component to help kill invading bacteria for millennia. Details about how bleach kills—and how bacteria can survive the attack—may lead to the development of new drugs.
In a study published in the April 6 online edition of the journal Nature, a team of Columbia University Medical Center researchers led by Ellen Lumpkin, PhD, associate professor of somatosensory biology, solve an age-old mystery of touch: how cells just beneath the skin surface enable us to feel fine details and textures.
Researchers at the University of California, San Diego School of Medicine have found that too little or too much of an enzyme called SRPK1 promotes cancer by disrupting a regulatory event critical for many fundamental cellular processes, including proliferation.
In textbooks, the grand-finale of cell division is the tug-of-war fought inside dividing cells as duplicated pairs of chromosomes get dragged in opposite directions into daughter cells. This process, called mitosis, is visually stunning to observe under a microscope. Equally stunning to cell biologists are the preparatory steps cells take to ensure that the process occurs safely.
Tweaking a specific cell type’s ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington’s disease, reports a UCLA study in Nature Neuroscience. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans.
Scientists at the Center for Nanotechnology and Nanotoxicology at Harvard School of Public Health have discovered a way to measure the effective density of engineered nanoparticles in physiological fluids, making it possible to determine the amount of nanomaterials that come into contact with cells and tissue in culture.
An international team of scientists led by Jef Boeke, PhD, director of NYU Langone Medical Center’s Institute for Systems Genetics, has synthesized the first functional chromosome in yeast, an important step in the emerging field of synthetic biology, designing microorganisms to produce novel medicines, raw materials for food, and biofuels.
Mitochondria, long known as “cellular power plants” for their generation of the key energy source adenosine triphosphate (ATP), are essential for proper cellular functions. Mitochondrial defects are often observed in a variety of diseases, including cancer, Alzheimer’s disease, and Parkinson’s disease, and are the hallmarks of a number of untreatable genetic mitochondrial disorders whose manifestations range from muscle weakness to organ failure. Whitehead Institute scientists have identified a protein whose inhibition could hold the key to alleviating suffering caused by such disorders.
Infectious disease specialists at the Johns Hopkins Children’s Center have identified a protein that regulates the body’s immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can lead to devastating illness in newborns and those with weakened immune systems.
Just as archeologists try to decipher ancient tablets to discern their meaning, UT Southwestern Medical Center cancer biologists are working to decode the purpose of an ancient gene considered one of the most important in cancer research.
Premi Haynes, a physiology Ph.D. candidate in the Campbell Muscle Lab, has documented the different cellular patterns and mechanical functions in contractions of the human heart. The findings indicate possible therapeutic targets for treatment of disease and heart failure.
New research suggests that gut microorganisms do not merely influence immune cell function, but also support the production of immune cells that form the first line of defense against infection. By understanding the mechanisms responsible for maintaining and replacing immune cells, researchers hope to one day develop targeted therapies to support and boost immune function in humans.
The tumor suppressor p53 does all it can to prevent oncogenes from transforming normal cells into tumor cells. Sometimes oncogenes manage to initiate tumor development in the presence of p53, which focuses its efforts instead on limiting the tumor’s ability to invade and metastasize. Researchers uncover one way that p53 acts to prevent cancer cell invasion.
The process of producing high-quality, fertile sperm requires many steps. Researchers show the transcription factor p73 promotes this process by regulating the adhesions between developing sperm and their support cells.
Biologists have discovered that when biological signals hit cells in rhythmic waves, the magnitude of the cells' response can depend on the number of signaling cycles — not their strength or duration.
Scientists at Indiana University have unlocked one of the mysteries of modern genetics: how acquired traits can be passed between generations in a process called epigenetic inheritance.
RNA encodes the proteins that play a key role in cellular reproduction, but the manner in which cells regulate its removal once these proteins are synthesized remains a mystery. One piece of this mystery has been solved as researchers at the University of North Carolina at Chapel Hill who have identified the steps by which a cell removes RNA from the cytoplasm.
Adenomatous polyposis coli is critical in protecting against colon cancer. KU Cancer Center researchers have shown that APC stationed in the nucleus is necessary to suppress Wnt and its signaling partners.
The immune system plays a pivotal role in targeting cancer cells for destruction. However, tumor cells are smart and have developed ways to avoid immune detection. A collaborative team of researchers at Moffitt Cancer Center recently discovered a novel mechanism that lung cancer cells use to block detection by a type of immune cell called a natural killer cell (NK cell).
The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital’s Quebec Leukemia Cell Bank, recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.
A team of biologists and engineers at the University of California, San Diego has discovered that white blood cells, which repair damaged tissue as part of the body’s immune response, move to inflamed sites by walking in a stepwise manner. The cells periodically form and break adhesions mainly under two “feet,” and generate the traction forces that propel them forward by the coordinated action of contractile proteins. Their discovery, published March 17 in the Journal of Cell Biology, is an important advance toward developing new pharmacological strategies to treat chronic inflammatory diseases such as arthritis, irritable bowel syndrome, Type 1 diabetes, and multiple sclerosis.
A Stony Brook University-led international research team has discovered how a cellular protein, STAT3, which is overactive in a majority of cancers, interferes with an antitumor mechanism in cells and therefore promotes the growth of cancer.
New research by UC San Francisco neuroscientists suggests that the body may get help in fast-changing situations from a specialized brain circuit that causes visual system neurons to fire more strongly during locomotion.
Heart attack and stroke are among the most serious threats to health. But novel research at UT Southwestern Medical Center has linked two major biological processes that occur at the onset of these traumatic events and, ultimately, can lead to protection for the heart.
Studying epithelial cells, the cell type that most commonly turns cancerous, Johns Hopkins researchers have identified a protein that causes cells to release from their neighbors and migrate away from healthy mammary, or breast, tissue in mice.
Although long recognized as an essential defense against the lung-invading fungus Asperfillus fumigatus, Neutrophils actually require a little help from fellow immune cells, according to a study by Amariliz Rivera, her colleagues at Rutgers New Jersey Medical School and scientists at the Fred Hutchinson Cancer Research Center in Seattle.
Cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego have identified a small, but powerful, new player in the onset and progression of heart failure. Their findings, published in the journal Nature on March 12, also show how they successfully blocked the newly discovered culprit to halt the debilitating and chronic life-threatening condition in its tracks.
The nucleoside adenosine—a tiny chemical structure made up of a simple base linked to a sugar—is critical for the regulation of bodily functions ranging from blood flow to tissue repair to sleep. Now, researchers at Rutgers New Jersey Medical School show that adenosine is essential in promoting the development of a type of immune response that helps oust gut-infecting worms.
Introducing three proteins that control the regulation of DNA in the nucleus -- called transcription factors -- into an immune-deficient mouse turned a specific group of cells in the gut lining into beta-like cells.
Discovering where a common virus hides in the body has been a long-term quest for scientists. Up to 80 percent of adults harbor the human cytomegalovirus (HCMV), which can cause severe illness and death in people with weakened immune systems. Now, researchers report that stem cells that encircle blood vessels can be a hiding place, suggesting a potential treatment target.
Biologists have believed that cancers cells spread through the body in a slow, aimless fashion, resembling a drunk who can't walk three steps in a straight line. They now know that's true in a flat petri dish, but not in the three-dimensional space of an actual body.
Kinases are proteins that play vital roles in disease, but scientists have struggled to study how they interact in real time. The lab of UNC's Klaus Hahn has developed a new technique to make these interactions occur and then watch them in real time to reveal some underlying causes of metastasis.
Springing clocks forward by an hour this Sunday is one example of an activity that can disrupt our daily rhythms. NIH-funded researchers are piecing together the molecular mechanisms of our biological clocks to better understand the intricate relationship among these clocks, daily rhythms and physiology.
Writing in the journal Molecular Cell, a team led by Mikhail Nikiforov, PhD, has identified a previously unrecognized feed-forward mechanism of reactive-oxygen-species regulation.
A new study in Cell Reports identifies a gene important to breast development and breast cancer, providing a potential new target for drug therapies to treat aggressive types of breast cancer.
An enzyme that helps maintain immune system function by “throwing away” a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests. The finding suggests the enzyme could be a target for drugs used to treat allergic asthma.
Like mobsters following strict orders, newly engineered molecules called “ubiquibodies” can mark specific proteins inside a cell for destruction – a molecular kiss of death that is paving the way for new drug therapies and powerful research tools.